5 results
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
pharmacotherapy trials in BPD ... following outcomes: BPD ... symptoms, mental ... the UK national BPD ... #BPD #Borderline
Lithium Therapy for Bipolar Disorder 
Toxicity Levels: 
 - Mild (1-1.5 mEq/L) 
 - Moderate (1.6-2.5
gain Toxicity Symptoms ... maintenance agent for treatment ... experience a variety of symptoms ... #Disorder #BPD ... #Toxicity #Pharmacology
Benzodiazepine (BZD) withdrawal: clinical findings and complications

 • Activation of ACC and OFC -> Feelings of
Benzodiazepine (BZD ... Activity -> Incr BP ... #withdrawal #pharmacology ... #pathophysiology ... diagnosis #signs #symptoms
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
hours or longer/BP ... Etiology: • Pathophysiology ... Neurological symptoms ... patients - 10-25% BP ... overaggressive BP
Therapy for Benign Prostatic Hyperplasia (BPH) 
5 Alpha-Reductase inhibitors
 • Flnasterlde and dutasterlde act by reducing
Prostatic Hyperplasia (BPH ... Treatment for 6 ... of BPH, such as ... #Hyperplasia #BPH ... #Medications #Pharmacology